Literature DB >> 33579259

Health care professionals' perspectives on screening and management of gestational diabetes mellitus in public hospitals of South India - a qualitative study.

Biswamitra Sahu1, Giridhara R Babu2,3, Kaveri Siddappa Gurav2, Maithili Karthik2, Deepa Ravi2, Eunice Lobo2, Daisy Abu John2, Laura Oakley4,5, Eugene Oteng-Ntim6, Iliatha Papachristou Nadal4, Sanjay Kinra4.   

Abstract

BACKGROUND: Women developing Gestational Diabetes Mellitus (GDM) are subsequently at a higher risk of developing Type 2 Diabetes later in life. Screening and effective management of women with GDM are essential in preventing progression to type 2 diabetes mellitus. We aimed to explore the perspectives of healthcare providers regarding the barriers from the health system context that restrict the timely screening and effective management of GDM.
METHODS: We conducted six in-depth interviews of health care providers- four with nurses and two with obstetricians in the public hospitals in India's major city (Bengaluru). The interviews were conducted in the preferred language of the participants (Kannada for nurses, English for the obstetricians) and audio-recorded. All Kannada interviews were transcribed and translated into English for analysis. The primary data were analyzed using the grounded theory approach by NVivo 12 plus. The findings are put into perspective using the socio-ecological model.
RESULTS: Health care providers identified delayed visits to public hospitals and stress on household-level responsibilities as barriers at the individual level for GDM screening. Also, migration of pregnant women to their natal homes during first pregnancy is a cultural barrier in addition to health system barriers such as unmet nurse training needs, long waiting hours, uneven power dynamics, lack of follow-up, resource scarcity, and lack of supportive oversight. The barriers for GDM management included non-reporting women to follow - up visits, irregular self-monitoring of drug and blood sugar, trained staff shortage, ineffective tracking, and lack of standardized protocol.
CONCLUSION: There is a pressing need to develop and improve existing GDM Screening and Management services to tackle the growing burden of GDM in public hospitals of India.

Entities:  

Keywords:  Gestational diabetes mellitus; Health care providers; India; Management; Public sector; Screening; Socio-ecological model

Mesh:

Year:  2021        PMID: 33579259      PMCID: PMC7881531          DOI: 10.1186/s12913-021-06077-0

Source DB:  PubMed          Journal:  BMC Health Serv Res        ISSN: 1472-6963            Impact factor:   2.655


  4 in total

1.  Exploring Factors Affecting Health Care Providers' Behaviors for Maintaining Continuity of Care in Kerala, India; A Qualitative Analysis Using the Theoretical Domains Framework.

Authors:  Linju Joseph; Sheila Greenfield; Anna Lavis; T R Lekha; Jeemon Panniyammakal; Semira Manaseki-Holland
Journal:  Front Public Health       Date:  2022-07-08

2.  Diagnosing Gestational Diabetes with a Probably Too Simplified Diagnostic Procedure Compared to International Criteria: The Indian Case Study.

Authors:  Francesco Corrado; Antonino Di Benedetto; Giacoma Di Vieste; Laura La Fauci; Canio Martinelli; Rosario D'Anna; Basilio Pintaudi
Journal:  J Clin Med       Date:  2022-06-28       Impact factor: 4.964

3.  The Perspectives of Diabetes Educators and Dietitians on Diet and Lifestyle Management for Gestational Diabetes Mellitus: A Qualitative Study.

Authors:  Amber J Hanks; Clare Hume; Siew Lim; Jessica A Grieger
Journal:  J Diabetes Res       Date:  2022-06-22       Impact factor: 4.061

4.  Educational films for improving screening and self-management of gestational diabetes in India and Uganda (GUIDES): study protocol for a cluster-randomised controlled trial.

Authors:  Laura L Oakley; Deepa R; Arthur Namara; Biswamitra Sahu; Iliatha Papachristou Nadal; Yamuna Ana; Helen Coombe; Eugene Oteng-Ntim; Janet Seeley; Moffat Nyirenda; Giridhar Babu; Sanjay Kinra
Journal:  Trials       Date:  2021-07-28       Impact factor: 2.279

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.